Skip to main content

Table 1 Clinical characteristics of alloHSCT patients

From: Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation

 

n=15

%

Median age (range)

57 (28–68)

 

<50

5

30

>50

10

70

Sex

  

female

8

53

male

7

47

Diagnosis

  

AML

13

87

ALL

2

13

Transplant

  

MUD

10

70

MRD

5

30

Conditioning

  

full intensity

8

53

47 reduced intensity

7

47

GvHD (acute = + Chronic)

  

yes

16

89

no

2

11

  1. AML, acute myeloid leukemia; MUD, matched unrelated donor; MRD, matched related donor; GvHD, graft-versus-host disease.